期刊文献+

人源化抗p185单链抗体/人白细胞介素-2双功能融合蛋白在293细胞中的高效表达 被引量:2

High efficient expression of a humanized single-chain Fv antibody/human interleukin-2 fusion protein directed against p185 in 293 cell line
原文传递
导出
摘要 目的 在 2 93细胞中表达人源化单链抗体 /人白细胞介素 2 (hIL 2 )双功能融合蛋白及评价其生物学活性。方法 将构建的表达载体转染 2 93细胞 ,G418筛选阳性克隆建立稳定表达细胞系 ,免疫印迹法 (Westernblot)、酶联免疫吸附试验 (ELISA )及 [3 H]脱氧胸苷 (3 H TdR)渗入法检测细胞上清中融合蛋白浓度和生物学活性。结果 融合蛋白浓度达 (10 2 .0± 4.2 ) g/L ,5 μl细胞上清即可在 45× 10 3 处呈现清晰蛋白条带。其中hIL 2无活性丢失 ,与标准对照比较差异无显著性 (P >0 .0 5 ) ;抗体的抗原结合活性有部分下降 ,与标准对照比较差异有非常显著性 (P <0 .0 1)。结论 该融合蛋白可在 2 93细胞系中得到高效表达 ,其中hIL 2部分无活性丢失 。 Objective To express a bispecific humanized single-chain Fv antibody/human IL-2 fusion protein against p185 in 293 cell line and verify its bioactivities.Methods The constructed expression vectors were transfected into 293 cells.The positive clone was obtained to make stable cell line with G418 selection.Western Blot,ELISA and 3H-TdR were used to measure the concentration of the fusion protein and its bioactivities in the supernatant.Results The concentration of fusion protein was (102.0±4.2) mg/L in supernatant,and only 5 μl of the supernatant was able to be shown to migrate as single band of 45×10 3 by Western blot analysis.The fusion protein was determined to retain the bioactivities of hIL-2 (P>0.05 vs standard rhIL-2).The loss of antigen-binding activity was shown to be less two orders of magnitude than that of 520C9-rhIL-2 chemical conjugate (P<0.01).Conclusion The fusion protein can be highly expressed in 293 cell line.The protein retained its hIL-2 bioactivities and acceptable antigen-binding specificity.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2003年第9期794-796,共3页 Chinese Journal of Experimental Surgery
  • 相关文献

参考文献1

二级参考文献11

  • 1Kayoko Nakamura,Atsushi Kubo.Effect of interleukin-2 on the biodistribution of technetium-99m-labelled anti-CEA monoclonal antibody in mice bearing human tumour xenografts[J].European Journal of Nuclear Medicine.1994(9)
  • 2Duncan RJS,Weston PD,Wrigglesworth RA.A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay[].Analytical Biochemistry.1983
  • 3Imagawa M,Yoshitake S,Hamaguchi Y,et al.Characteristics and evaluation of antibody-horseradish peroxides conjugates prepared by using a maleimide compound, glutaraldehyde,and periodate[].Journal of Applied Biochemistry.1982
  • 4Grimm EA,Mazumder A,Zhang HZ,et al.Lymphokineactivated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes[].The Journal of Experimental Medicine.1982
  • 5Gillies SD,Beilly EB,Lo KM,et al.Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells[].Proceedings of the National Academy of Sciences of the United States of America.1992
  • 6Sabzevari H,Gillies SD,Mueller BM,et al.A recombinant antibody-interleukin 2 fusion protein suppressed growth of hepatic human neuroblastoma metastasises in severe combined immunodeficiency mice[].Proceedings of the National Academy of Sciences of the United States of America.1994
  • 7Hennigan TW,Begent RHJ,Allen-Mersh TG.Histamine,leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model[].British Journal of Cancer.1991
  • 8Gillis S,Ferm MM,Ou W,et al.T cell growth factor:parameters of production and a quantitative microassay for activity[].J Immunol.1978
  • 9LeBerthon B,Khawli LA,Alauddin M,et al.Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate[].Cancer Research.1991
  • 10Riddles PW,Blakeley RL,Zerner B.Reassessment of Ellman’s reagent[].Methods in Enzymology.1983

共引文献2

同被引文献10

  • 1Wei-YunZHANG,Tak-ChunYIP,Cheuk-SangKWOK.Rapid Purification of a New Humanized Single-chain Fv Antibody/Human Interleukin-2 Fusion Protein Reactive against HER2 Receptor[J].Acta Biochimica et Biophysica Sinica,2004,36(10):707-712. 被引量:2
  • 2李方成,李军亮,刘然义,吴中华,张培峰.大鼠葡萄糖转运体3真核表达载体的构建及其在293细胞中的表达[J].中华实验外科杂志,2006,23(4):606-608. 被引量:1
  • 3Kliewer SA,Moore JT,Wade L,et al.An oiphan nuclear receptor acti-vated by pregnanes defines a novel steroid signaling pathway.Cell,1998,92:73-82.
  • 4Beato M,Herrlich P,Schutz G.Steroid hormone receptors:many actorsin search of a plot.Cell,1995,83:851-857.
  • 5Dai G,He L,Bu P,et al.Pregnane X receptor is essential for normalprogression of liver regeneration.Hepatology,2008,4:1277-1287.
  • 6Watkins RE,Wisely GB,Moore LB,et al.The human nuclear xenobi-otic receptor PXR:structural determinants of directed promiscuity.Science,2001,292:2329-2333.
  • 7Hustert E,Zibat A,Presecan-Siedel E,et al.Natural protein variantsof pregnane X receptor with altered transactivation activity towardCYP3A4.Drug Metab Dispos,2001,29:1454-1459.
  • 8Koyano S,Kurose K,Saito Y,et al.Functional characterization of fournaturally occurring variants of human pregnane X receptor(PXR):one variant causes dramatic loss of both DNA binding activity and thetransactivation of the CYP3A4 promoter/enhancer region.Drug MetabDispos,2004,32:149-154.
  • 9Lamba J,Lamba V,Schuetz E.Genetic variants of PXR(NR112)andCAR(NR113)and their implications in drug metabolism and phar-macogenetics.Curr Drug Metab,2005,6:369-383.
  • 10Healan-Greenberg C,Waring JF,Kempf DJ,et al.A human immunod-eficiency virus protease inhibitor is a novel functional inhibitor of hu-man pregnane X receptor.Drug Metab Dispos,2008,36:500-507.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部